Hessmann was suspended by the team following this discovery and has not raced since. The B-test had confirmed presence of the substance and then even jail time was on the table due to Germany's harsh rules against rule breaking. However the best possible case has emerged for Hessmann who managed to prove the likelihood of a contamination. Nevertheless, he still has to serve one more month of a four-month suspension.
"However, the NADA also believes that the risk of contaminated medication lies with the athlete and therefore proposed the lightest possible suspension of 4 months to Hessmann, with a retroactive effect of three months," the team explain. "That was accepted by the rider today. As a result, he is suspended for at least another month. After that,
Michel Hessmann and the team will consider how to proceed."
It is not known whether Hessmann will continue with the Dutch team or not following this case. The 23-year old has a contract until the end of this season. In 2022, he was third in the overall classification of the Tour de l'Avenir (most commonly known as the under-23 Tour de France), only behind fellow pros Cian Uijtdebroeks and Johannes Staune-Mittet who are both currently teammates at Visma.